The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Lipopolysaccharide (Endotoxin)-host defense antibacterial peptides interactions: Role in bacterial resistance and prevention of sepsis
Open accessAbstract
Lipopolysaccharide (LPS) is the major molecular component of the outer membrane of Gram-negative bacteria and serves as a physical barrier providing the bacteria protection from its surroundings. LPS is also recognized by the immune system as a marker for the detection of bacterial pathogen invasion, responsible for the development of inflammatory response, and in extreme cases to endotoxic shock. Because of these functions, the interaction of LPS with LPS binding molecules attracts great attention. One example of such molecules are antimicrobial peptides (AMPs). These are large repertoire of gene-encoded peptides produced by living organisms of all types, which serve as part of the innate immunity protecting them from pathogen invasion. AMPs are known to interact with LPS with high affinities. The biophysical properties of AMPs and their mode of interaction with LPS determine their biological function, susceptibility of bacteria to them, as well as the ability of LPS to activate the immune system. This review will discuss recent studies on the molecular mechanisms underlying these interactions, their effects on the resistance of the bacteria to AMPs, as well as their potential to neutralize LPS-induced endotoxic shock.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Raetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404
Mechanisms of Antimicrobial Peptide Action and Resistance
Yeaman, M. R., & Yount, N. Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.2 · Cited by 3,001
The immunopathogenesis of sepsis
Cohen, J. (2002) · Nature · doi:10.1038/nature01326 · Cited by 2,742
Phylogenetic Perspectives in Innate Immunity
Hoffmann, J. A., Kafatos, F. C., Janeway, C. A., & Ezekowitz, R. A. B. (1999) · Science · doi:10.1126/science.284.5418.1313 · Cited by 2,492
Zasloff, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5449 · Cited by 2,305
Shai, Y. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00200-x · Cited by 1,869
Self-citationPeptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2
Schwandner, R., Dziarski, R., Wesche, H., Rothe, M., & Kirschning, C. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17406 · Cited by 1,704
Peptide Antibiotics and Their Role in Innate Immunity
Boman, H. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.61 · Cited by 1,665
Mode of action of membrane active antimicrobial peptides
Shai, Y. (2002) · Peptide Science · doi:10.1002/bip.10260 · Cited by 1,576
Self-citationPrevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4
Pålsson‐McDermott, E. M., & O'Neill, L. A. J. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01976.x · Cited by 1,254
Amphipathic, α-helical antimicrobial peptides
Tossi, A., Sandri, L., & Giangaspero, A. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)55:1<4::aid-bip30>3.0.co;2-m · Cited by 1,247
The role of cationic antimicrobial peptides in innate host defences
Hancock, R. E. W., & Diamond, G. (2000) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01823-0 · Cited by 1,218
Mammalian defensins in the antimicrobial immune response
Selsted, M. E., & Ouellette, A. J. (2005) · Nature Immunology · doi:10.1038/ni1206 · Cited by 1,203
Bacterial lipopolysaccharides and innate immunity
Alexander, C., & Rietschel, E. T. (2001) · Journal of Endotoxin Research · doi:10.1179/096805101101532675 · Cited by 1,120
Matsuzaki, K. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00197-2 · Cited by 1,010
Defensins: Antimicrobial and Cytotoxic Peptides of Mammalian Cells
Lehrer, R. I., Lichtenstein, A. K., & Ganz, T. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.000541 · Cited by 991
The role of antimicrobial peptides in animal defenses
Hancock, R. E. W., & Scott, M. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.8856 · Cited by 971
A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence.
Miller, S. I., Kukral, A. M., & Mekalanos, J. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.13.5054 · Cited by 929
An angiogenic role for the human peptide antibiotic LL-37/hCAP-18
Koczulla, R., von Degenfeld, G., Kupatt, C., Krötz, F., Zahler, S., Gloe, T., Issbrücker, K., Unterberger, P., Zaiou, M., Lebherz, C., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17545 · Cited by 863
Mg2+ as an Extracellular Signal: Environmental Regulation of Salmonella Virulence
Véscovi, E. G., Soncini, F. C., & Groisman, E. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81003-x · Cited by 841
The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses
Scott, M. G., Davidson, D. J., Gold, M. R., Bowdish, D., & Hancock, R. E. W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3883 · Cited by 713
Lipid A Acylation and Bacterial Resistance against Vertebrate Antimicrobial Peptides
Guo, L., Lim, K. B., Poduje, C. M., Daniel, M., Gunn, J. S., Hackett, M., & Miller, S. I. (1998) · Cell · doi:10.1016/s0092-8674(00)81750-x · Cited by 649
Gudmundsson, G. H., Agerberth, B., Odeberg, J., Bergman, T., Olsson, B., & Salcedo, R. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0325z.x · Cited by 578
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
Larrick, J. W., Hirata, M., Balint, R. F., Lee, J., Zhong, J., & Wright, S. C. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1291-1297.1995 · Cited by 573
Heilborn, J. D., Nilsson, M. F., Sørensen, O., Ståhle-Bäckdahl, M., Kratz, G., Weber, G., & Borregaard, N. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12069.x · Cited by 572
Yang, D., Biragyn, A., Hoover, D. M., Lubkowski, J., & Oppenheim, J. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104603 · Cited by 572
Mookherjee, N., Brown, K. L., Bowdish, D. M. E., Doria, S., Falsafi, R., Hokamp, K., Roche, F. M., Mu, R., Doho, G. H., Pistolic, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2455 · Cited by 567
Recognition of Antimicrobial Peptides by a Bacterial Sensor Kinase
Bader, M. W., Sanowar, S., Daley, M. E., Schneider, A. R., Cho, U., Xu, W., Klevit, R. E., Le Moual, H., & Miller, S. I. (2005) · Cell · doi:10.1016/j.cell.2005.05.030 · Cited by 567
Toll receptors, CD14, and macrophage activation and deactivation by LPS
Dobrovolskaia, M. A., & Vogel, S. N. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01613-1 · Cited by 564
Recognition of Gram-negative bacteria and endotoxin by the innate immune system
Ulevitch, R. J., & Tobias, P. S. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80004-1 · Cited by 561
Chertov, O., Michiel, D. F., Xu, L., Wang, J. M., Tani, K., Murphy, W. J., Longo, D. L., Taub, D. D., & Oppenheim, J. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.6.2935 · Cited by 548
Agerberth, B., Gunne, H., Odeberg, J., Kogner, P., Boman, H. G., & Gudmundsson, G. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.1.195 · Cited by 503
Rietschel, E. T., Brade, H., Holst, O., Brade, L., Müller-Loennies, S., Mamat, U., Zähringer, U., Beckmann, F., Seydel, U., Brandenburg, K., et al. (1996) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-80186-0_3 · Cited by 469
Outer membrane barrier as a mechanism of antimicrobial resistance
Nikaido, H. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.11.1831 · Cited by 462
Wurfel, M. M., Kunitake, S. T., Lichenstein, H., Kane, J. P., & Wright, S. D. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1025 · Cited by 442
Role of lipoteichoic acid in infection and inflammation
Ginsburg, I. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00226-8 · Cited by 425
Gunn, J. S., & Miller, S. I. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.23.6857-6864.1996 · Cited by 409
FRAPPER FORT OU FRAPPER DOUCEMENT: A GRAM-NEGATIVE DILEMMA
BUXTONHOPKIN, D. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92170-0 · Cited by 403
A cathelicidin family of human antibacterial peptide LL‐37 induces mast cell chemotaxis
Niyonsaba, F., Iwabuchi, K., Someya, A., Hirata, M., Matsuda, H., Ogawa, H., & Nagaoka, I. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01398.x · Cited by 402
Miller, S. I., & Mekalanos, J. J. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.5.2485-2490.1990 · Cited by 395
The Role of Cathelicidins in the Innate Host Defenses of Mammals
(2005) · Current Issues in Molecular Biology · doi:10.21775/cimb.007.179 · Cited by 393
Transfer of palmitate from phospholipids to lipid A in outer membranes of Gram-negative bacteria
Bishop, R. E., Gibbons, H. S., Guina, T., Trent, M. S., Miller, S. I., & Raetz, C. R. H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.19.5071 · Cited by 388
PR39, a peptide regulator of angiogenesis
Li, J., Post, M., Volk, R., Gao, Y., Li, M., Metais, C., Sato, K., Tsai, J., Aird, W., Rosenberg, R. D., et al. (2000) · Nature Medicine · doi:10.1038/71527 · Cited by 386
SALMONELLOSIS: Host Immune Responses and Bacterial Virulence Determinants1
Jones, B. D., & Falkow, S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.533 · Cited by 385
Impact of LL-37 on anti-infective immunity
Bowdish, D. M. E., Davidson, D. J., Lau, Y. E., Lee, K., Scott, M. G., & Hancock, R. E. W. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0704380 · Cited by 374
Sørensen, O. E., Cowland, J. B., Theilgaard-Mönch, K., Liu, L., Ganz, T., & Borregaard, N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5583 · Cited by 370
Endotoxin (Lipopolysaccharide) Neutralization by Innate Immunity Host-Defense Peptides
Rosenfeld, Y., Papo, N., & Shai, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m504327200 · Cited by 370
Self-citationFrapper fort ou doucement:A Gramnegative dilemma.
Hopkin, B. D. A. (1978) · The Lancet · Cited by 358
Salmonella typhimurium phoP virulence gene is a transcriptional regulator.
Groisman, E. A., Chiao, E., Lipps, C. J., & Heffron, F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.7077 · Cited by 336
Immunomodulatory Activities of Small Host Defense Peptides
Bowdish, D. M. E., Davidson, D. J., Scott, M. G., & Hancock, R. E. W. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1727-1732.2005 · Cited by 316
Mor, A., Huong, N. V., Delfour, A., Migliore-Samour, D., & Nicolas, P. (1991) · Biochemistry · doi:10.1021/bi00100a014 · Cited by 313
Cationic Antimicrobial Peptides and Their Multifunctional Role in the Immune System
Scott, M. G., & Hancock, R. E. W. (2000) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v20.i5.40 · Cited by 286
Mor, A., Hani, K., & Nicolas, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31742-3 · Cited by 279
Braff, M. H., Hawkins, M. A., Nardo, A. D., Lopez-Garcia, B., Howell, M. D., Wong, C., Lin, K., Streib, J. E., Dorschner, R., Leung, D. Y. M., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4271 · Cited by 275
Scott, M. G., Vreugdenhil, A. C. E., Buurman, W. A., Hancock, R. E. W., & Gold, M. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.549 · Cited by 270
Resistance to host antimicrobial peptides is necessary for Salmonella virulence.
Groisman, E. A., Parra-Lopez, C., Salcedo, M., Lipps, C. J., & Heffron, F. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.11939 · Cited by 265
Nagaoka, I., Hirota, S., Niyonsaba, F., Hirata, M., Adachi, Y., Tamura, H., & Heumann, D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3329 · Cited by 258
Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure
Shaykhiev, R., Beißwenger, C., Kändler, K., Senske, J., Püchner, A., Damm, T., Behr, J., & Bals, R. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00286.2004 · Cited by 254
Papo, N., & Shai, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412865200 · Cited by 253
Self-citationCiornei, C. D., Sigurdardóttir, T., Schmidtchen, A., & Bodelsson, M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2845-2850.2005 · Cited by 247
Gutsmann, T., Müller, M., Carroll, S. F., MacKenzie, R. C., Wiese, A., & Seydel, U. (2001) · Infection and Immunity · doi:10.1128/iai.69.11.6942-6950.2001 · Cited by 229
Kurosaka, K., Chen, Q., Yarovinsky, F., Oppenheim, J. J., & Yang, D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6257 · Cited by 222
Trent, M. S., Pabich, W., Raetz, C. R. H., & Miller, S. I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010730200 · Cited by 201
Biological Properties of Structurally Related α-Helical Cationic Antimicrobial Peptides
Scott, M. G., Yan, H., & Hancock, R. E. W. (1999) · Infection and Immunity · doi:10.1128/.67.4.2005-2009.1999 · Cited by 189
Function and therapeutic potential of host defence peptides
Mcphee, J. B., & Hancock, R. E. W. (2005) · Journal of Peptide Science · doi:10.1002/psc.704 · Cited by 182
Ooi, C. E., Weiss, J., Doerfler, M. E., & Elsbach, P. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.649 · Cited by 181
Structure-Activity Relationship of Synthetic Toll-like Receptor 4 Agonists
Stöver, A. G., Correia, J. D. S., Evans, J. T., Cluff, C. W., Elliott, M. W., Jeffery, E. W., Johnson, D. A., Lacy, M. J., Baldridge, J. R., Probst, P., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310760200 · Cited by 162
Nagaoka, I., Hirota, S., Niyonsaba, F., Hirata, M., Adachi, Y., Tamura, H., Tanaka, S., & Heumann, D. (2002) · Clinical and Vaccine Immunology · doi:10.1128/cdli.9.5.972-982.2002 · Cited by 160
Interaction of Cationic Peptides with Lipoteichoic Acid and Gram-Positive Bacteria
Scott, M. G., Gold, M. R., & Hancock, R. E. W. (1999) · Infection and Immunity · doi:10.1128/iai.67.12.6445-6453.1999 · Cited by 153
Lipoproteins inhibit macrophage activation by lipoteichoic acid
Grünfeld, C., Marshall, M. K., Shigenaga, J. K., Moser, A. H., Tobias, P. S., & Feingold, K. R. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33363-0 · Cited by 147
Neutrophil Defensins Enhance Lung Epithelial Wound Closure and Mucin Gene Expression In Vitro
Aarbiou, J., Verhoosel, R. M., van Wetering, S., de Boer, W. I., van Krieken, J. H., Litvinov, S. V., Rabe, K. F., & Hiemstra, P. S. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0267oc · Cited by 143
A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity.
Larrick, J. W., Hirata, M., Zheng, H., Zhong, J., Bolin, D., Cavaillon, J., Warren, H. S., & Wright, S. C. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.1.231 · Cited by 142
PhoP‐regulated Salmonella resistance to the antimicrobial peptides magainin 2 and polymyxin B
Shi, Y., Cromie, M. J., Hsu, F., TURK, J. W., & Groisman, E. A. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04107.x · Cited by 138
Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin
Schimke, J., Mathison, J. C., Morgiewicz, J., & Ulevitch, R. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13875 · Cited by 134
Ginsburg, I. (2002) · Apmis · doi:10.1034/j.1600-0463.2002.1101101.x · Cited by 126
David, S. A. (2001) · Journal of Molecular Recognition · doi:10.1002/jmr.549 · Cited by 116
Calcitermin, a novel antimicrobial peptide isolated from human airway secretions
Cole, A. M., Kim, Y., Tahk, S., Hong, T., Weis, P., Waring, A. J., & Ganz, T. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02731-4 · Cited by 105
Andrä, J., Koch, M. H. J., Bartels, R., & Brandenburg, K. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1593-1599.2004 · Cited by 104
Hardaway, R. M. (2000) · The American Surgeon · doi:10.1177/000313480006600105 · Cited by 104
Banemann, A., Deppisch, H., & Gross, R. (1998) · Infection and Immunity · doi:10.1128/iai.66.12.5607-5612.1998 · Cited by 99
Andrä, J., Lohner, K., Blondelle, S. E., Jerala, R., Moriyón, I., KOCH, M. H. J., Garidel, P., & Brandenburg, K. (2004) · Biochemical Journal · doi:10.1042/bj20041270 · Cited by 98
Endotoxin Neutralizing Peptides
Jerala, R., & Porro, M. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043388079 · Cited by 91
Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity
Hirata, M., Shimomura, Y., Yoshida, M., Morgan, J. G., Palings, I., Wilson, D., Yen, M. H., Wright, S. C., & Larrick, J. W. (1994) · Infection and Immunity · doi:10.1128/iai.62.4.1421-1426.1994 · Cited by 88
Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor
Warren, H. S., Glennon, M. L., Wainwright, N., Amato, S. F., Black, K. M., Kirsch, S. J., Riveau, G. J., Whyte, R. I., Zapol, W. M., & Novitsky, T. J. (1992) · Infection and Immunity · doi:10.1128/iai.60.6.2506-2513.1992 · Cited by 86
Rana, F. R., Macias, E. A., Sultany, C. M., Modzrakowski, M. C., & Blazyk, J. (1991) · Biochemistry · doi:10.1021/bi00238a008 · Cited by 86
Chen, Q., Wade, D. C., Kurosaka, K., Wang, Z. Y., Oppenheim, J. J., & Yang, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2652 · Cited by 78
Potential Therapeutic Role of Cationic Peptides in Three Experimental Models of Septic Shock
Giacometti, A., Cirioni, O., Ghiselli, R., Mocchegiani, F., Prete, M. S. D., Viticchi, C., Kamysz, W., Łempicka, E., Saba, V., & Scalise, G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2132-2136.2002 · Cited by 57
Novel therapies for sepsis: antiendotoxin therapies
Manocha, S., Feinstein, D., Kumar, A., & Kumar, A. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.12.1795 · Cited by 49
de Haas, C. J. C., van Leeuwen, H. J., Verhoef, J., van Kessel, K. P. M., & van Strijp, J. A. G. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00207-6 · Cited by 45
Gutsmann, T., Hagge, S. O., David, A., Roes, S., Böhling, A., Hammer, M. U., & Seydel, U. (2005) · Journal of Endotoxin Research · doi:10.1177/09680519050110030501 · Cited by 43
Brackett, D. J., Lerner, M. R., Lacquement, M. A., He, R., & Pereira, H. A. (1997) · Infection and Immunity · doi:10.1128/iai.65.7.2803-2811.1997 · Cited by 42
Hirata, M., Shimomura, Y., Yoshida, M., Wright, S. C., & Larrick, J. W. (1994) · PubMed · Cited by 34
Koyama, Y., Motobu, M., Hikosaka, K., Yamada, M., Nakamura, K., Saido‐Sakanaka, H., Asaoka, A., Yamakawa, M., Sekikawa, K., Kitani, H., et al. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.08.008 · Cited by 22
Gutsmann, T., Fix, M., Larrick, J. W., & Wiese, A. (2000) · The Journal of Membrane Biology · doi:10.1007/s002320010023 · Cited by 20
Motobu, M., Amer, S., Yamada, M., Nakamura, K., Saido‐Sakanaka, H., Asaoka, A., Yamakawa, M., & Hirota, Y. (2004) · Journal of Veterinary Medical Science · doi:10.1292/jvms.66.319 · Cited by 15
Butler, T., & Möller, G. (1977) · Infection and Immunity · doi:10.1128/iai.18.2.400-404.1977 · Cited by 13
Cited by
Studies on anticancer activities of antimicrobial peptides
Hoskin, D. W., & Ramamoorthy, A. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.11.008 · Cited by 1,296
Toxicity Mechanisms in Escherichia coli Vary for Silver Nanoparticles and Differ from Ionic Silver
Ivask, A., ElBadawy, A., Kaweeteerawat, C., Boren, D., Fischer, H., Ji, Z., Chang, C. H., Liu, R., Tolaymat, T., Telesca, D., et al. (2014) · ACS Nano · doi:10.1021/nn4044047 · Cited by 599
The human cathelicidin LL-37 — A pore-forming antibacterial peptide and host-cell modulator
Xhindoli, D., Pacor, S., Benincasa, M., Scocchi, M., Gennaro, R., & Tossi, A. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.11.003 · Cited by 366
Bacterial Resistance to Antimicrobial Agents
Varela, M. F., Stephen, J., Lekshmi, M., Ojha, M., Wenzel, N., Sanford, L. M., Hernandez, A. J., Parvathi, A., & Kumar, S. H. (2021) · Antibiotics · doi:10.3390/antibiotics10050593 · Cited by 292
Inflammation, sleep, obesity and cardiovascular disease
Miller, M., & Cappuccio, F. (2007) · Current Vascular Pharmacology · doi:10.2174/157016107780368280 · Cited by 233
Metadata
- Authors
- Rosenfeld, Y., & Shai, Y.
- Venue
- Biochimica et Biophysica Acta (BBA) - Biomembranes
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 1758
- Issue
- 9
- Pages
- 1513-1522
- ISSN
- 0005-2736 (ISSN-L)
- OpenAlex
- W2013160328
- Cited by
- 318
- References
- 99
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.